Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(6 sites)
United States
Mayo Clinic in Rochester, Rochester, Minnesota Siteman Cancer Center at Washington University, St Louis, Missouri Hackensack University Medical Center, Hackensack, New Jersey Memorial Sloan Kettering Cancer Center, New York, New York UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah Age range
18 Years and older
Last updated September 2024